Thursday, February 20, 2025

Scientists identify a new cancer immunotherapy target: Dysfunctional B cells

Scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood -- known as the tertiary lymphoid structure -- where they become frustratingly dysfunctional when in close contact with tumors.

from Top Health News -- ScienceDaily https://ift.tt/8uyKE31
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001...